62 related articles for article (PubMed ID: 7545456)
1. T-lymphoblastic lymphoma/leukemia cells negative for CD52 and CD59.
Iwamoto N; Nagakura S; Kawaguchi T; Horikawa K; Takatsuki K; Nakakuma H
Int J Hematol; 1995 Jul; 62(1):55-7. PubMed ID: 7545456
[No Abstract] [Full Text] [Related]
2. A T-lineage neoplasm-Which one?
Bain BJ; Fawcett N
Am J Hematol; 2009 Oct; 84(10):678. PubMed ID: 19373891
[No Abstract] [Full Text] [Related]
3. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
4. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
5. CD7, CD4 and myeloid antigen-positive acute lymphoblastic leukemia.
Nakase K; Kita K; Sekine T; Otsuji A; Shirakawa S; Tsuji K; Miyanishi E; Asou H; Kamada N
Int J Hematol; 1993 Dec; 59(1):41-6. PubMed ID: 7909241
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
[TBL] [Abstract][Full Text] [Related]
7. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia.
Sartor M; Bradstock K
Cytometry; 1994 Sep; 18(3):119-22. PubMed ID: 7813331
[TBL] [Abstract][Full Text] [Related]
8. Gene rearrangements in T-cell lymphoblastic lymphoma.
Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes.
Luczynski W; Krawczuk-Rybak M; Muszynska-Roslan K; Stasiak-Barmuta A; Zak J
Med Pediatr Oncol; 2002 Aug; 39(2):147-8. PubMed ID: 12116070
[No Abstract] [Full Text] [Related]
10. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of SRIK-NKL: a novel CD8+ natural killer/T cell line derived from a patient with leukemic phase of acute lymphoblastic lymphoma.
Srivastava BI; Srivastava MD
Leuk Res; 2005 Jul; 29(7):771-83. PubMed ID: 15927673
[TBL] [Abstract][Full Text] [Related]
12. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
[TBL] [Abstract][Full Text] [Related]
13. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of cytoplasmic antigens in acute leukemia by flow cytometry].
Kawai S; Zha Z; Yamamoto Y; Nakadate H; Kawakami K; Kikuta A; Utsumi J; Nishikawa K; Mimaya J; Miyake M
Rinsho Ketsueki; 1993 Jan; 34(1):13-20. PubMed ID: 8450602
[TBL] [Abstract][Full Text] [Related]
15. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
[TBL] [Abstract][Full Text] [Related]
16. [Expression of myeloid antigen in childhood acute lymphoblastic leukemia].
Hu Q; Zhang LQ; Liu SY; Guo YJ; Tao DD
Zhonghua Er Ke Za Zhi; 2003 May; 41(5):370-1. PubMed ID: 14751063
[No Abstract] [Full Text] [Related]
17. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
18. A γ/δ T-cell receptor prolymphocytic leukemia and CD4-/CD8- double-negative immunophenotype in a pediatric patient.
Moser AM; Quider AA; Groen JA; Shubinsky G; Kapelushnik J
J Pediatr Hematol Oncol; 2015 May; 37(4):e218-9. PubMed ID: 25757027
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
Babusíková O; Glasová M; Kusenda J; Koníková E; Mésárosová A
Neoplasma; 1994; 41(6):305-13. PubMed ID: 7870213
[TBL] [Abstract][Full Text] [Related]
20. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
